-
-
-
-
-
-
-
Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Year Ended 2025
-
-
-
-
-
-
-
Dermata Therapeutics Announces Closing of up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
-
-
-
-
-
-
-
Dermata Announces Acceptance of Patent Application for Next-Generation Acne Treatment by Australian Patent Office
-
-
-
-
-
-
-
Dermata Receives Notice of Grant of Australian Patent for Topical Botulinum Toxin Treatment for Hyperhidrosis
-
-
-
-
-
-
-
Dermata Therapeutics, Inc (DRMA) Halted, News Pending
-
-
-
-
-
-
-
Dermata Therapeutics Announces $2.55 Million Private Placement Priced At-The-Market Under Nasdaq Rules
-
-
-
-
-
-
-
Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results
-
408,269 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

